Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More
Xconomy
AUGUST 12, 2016
government’s Precision Medicine Initiative is an ambitious effort to collect the genomic data of 1 million Americans, and tech giant Alphabet (NASDAQ: GOOG ) is deeply involved. . —The U.S. Alex Lash examined the company’s role, via its biotech subsidiary Verily Life Sciences, in the massive project. —David H.
Let's personalize your content